Your browser doesn't support javascript.
loading
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.
La Rocca, Francesco; Airoldi, Irma; Di Carlo, Emma; Marotta, Pina; Falco, Geppino; Simeon, Vittorio; Laurenzana, Ilaria; Trino, Stefania; De Luca, Luciana; Todoerti, Katia; Villani, Oreste; Lackmann, Martin; D'Auria, Fiorella; Frassoni, Francesco; Neri, Antonino; Del Vecchio, Luigi; Musto, Pellegrino; Cilloni, Daniela; Caivano, Antonella.
Afiliación
  • La Rocca F; Laboratory of Pre-clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata (CROB), via Padre Pio, 1, 85028, Rionero in Vulture, Italy. francesco.larocca@crob.it.
  • Airoldi I; Laboratorio di Oncologia, IRCCS - G. Gaslini Institute, Genoa, Italy.
  • Di Carlo E; Ce.S.I.-MeT, Aging Research Center, Pathological Anatomy and Immuno-Oncology Unit, and Department of Medicine and Sciences of Aging, "G. D'Annunzio" University, Chieti, Italy.
  • Marotta P; Department of Stem Cell and Development, Istituto di Ricerche Genetiche Gaetano Salvatore Biogem scarl, Ariano Irpino, Italy.
  • Falco G; Department of Stem Cell and Development, Istituto di Ricerche Genetiche Gaetano Salvatore Biogem scarl, Ariano Irpino, Italy.
  • Simeon V; Department of Biology, University of Naples "Federico II", Naples, Italy.
  • Laurenzana I; Laboratory of Pre-clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata (CROB), via Padre Pio, 1, 85028, Rionero in Vulture, Italy.
  • Trino S; Laboratory of Pre-clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata (CROB), via Padre Pio, 1, 85028, Rionero in Vulture, Italy.
  • De Luca L; Laboratory of Pre-clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata (CROB), via Padre Pio, 1, 85028, Rionero in Vulture, Italy.
  • Todoerti K; Laboratory of Pre-clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata (CROB), via Padre Pio, 1, 85028, Rionero in Vulture, Italy.
  • Villani O; Laboratory of Pre-clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata (CROB), via Padre Pio, 1, 85028, Rionero in Vulture, Italy.
  • Lackmann M; Department of Onco-Hematology, IRCCS-CROB, Rionero in Vulture, Italy.
  • D'Auria F; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia.
  • Frassoni F; Laboratory of Clinical Research and Advanced Diagnostics, IRCCS-CROB, Rionero in Vulture, Italy.
  • Neri A; Laboratorio Cellule Staminali post-natali e Terapie Cellulari, IRCCS - G. Gaslini Institute, Genoa, Italy.
  • Del Vecchio L; Department of Clinical Sciences and Community Health, University of Milan and Hematology, Fondazione Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Musto P; Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy.
  • Cilloni D; CEINGE-Biotecnologie Avanzate scarl, Naples, Italy.
  • Caivano A; Scientific Direction, IRCCS-CROB, Rionero in Vulture, Italy.
Cell Oncol (Dordr) ; 40(5): 483-496, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28721629
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Movimiento Celular / Receptor EphA3 / Mieloma Múltiple / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Oncol (Dordr) Año: 2017 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Movimiento Celular / Receptor EphA3 / Mieloma Múltiple / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Oncol (Dordr) Año: 2017 Tipo del documento: Article País de afiliación: Italia